ANZ Breast Cancer Trials Group Limited
Breast Cancer Trials | Breast Cancer Research
64051369496
NSW 2300
breastcancertrials.org.au
BCTrialsANZ
BreastCancerTrials
2482852
ANZ Breast Cancer Trials Group Limited
The ANZ Breast Cancer Trials Group Limited, operating as Breast Cancer Trials (BCT), is an Australian nonprofit clinical trials research organisation focused on improving breast cancer treatments and prevention strategies. Established in 1978, it coordinates multicentre national and international clinical trials across Australia and New Zealand, involving over 980 researchers at 118 institutions as of 2024[^1^][^3^].
Mission and Activities
BCT’s primary mission is to develop innovative therapies and prevention approaches through collaborative clinical trials. Its research has directly contributed to global advancements in breast cancer management, including changes to standard treatment protocols. The organisation emphasises participant-focused trials, with over 17,000 individuals enrolled across 93 trials since its inception[^3^][^5^].
Collaboration and Impact
The group facilitates partnerships between researchers, clinicians, and trial participants, operating as Australia’s largest independent breast cancer trials charity[^5^]. Its work spans treatment efficacy, survivorship, and risk-reduction strategies, aiming to reduce mortality and improve quality of life for patients[^1^][^3^].
Note: The provided ABN (64051369496RR0001) does not match public records; official sources cite ABN 61426486715 for the entity[^5^].
[^1^]: Breast Cancer Trials. “Who We Are.” breastcancertrials.org.au.
[^3^]: “About Breast Cancer Trials.” Breast Cancer Trials.
[^5^]: Cancer Council Victoria. “Breast Cancer Trials.” My Cancer Guide, 2024.
[1] https://www.breastcancertrials.org.au [2] https://www.acnc.gov.au/charity/charities/cf487a12-2caf-e811-a95e-000d3ad24c60 [3] https://www.breastcancertrials.org.au/who-we-are/ [4] https://www.acnc.gov.au/charity/charities/cf487a12-2caf-e811-a95e-000d3ad24c60/documents/27e679d8-0ad9-e911-a813-000d3ad1f9f4 [5] https://www.cancervic.org.au/cancer-support-services/Service.aspx?ID=breast-cancer-trials
Podobné organizace
Breast Cancer Research Centre - Western Australia |
|
Anzup Cancer Trials Group Limited |
|
National Breast Cancer Foundation |
|
Australia New Zealand Gynaecological Oncology Group |
|
ICON CANCER FOUNDATION LTD |
Podobné organizace global
Breast Cancer Research Foundation |
|
No Surrender Breast Cancer Foundation Inc |
|
Ecog-Acrin Medical Research Foundation Inc |
|
American Breast Cancer Prevention Foundation |
|
BREAST CANCER RESEARCH AID (BCRA) |
Podobná návštěvnost
Art Salon S, z. s. |
|
OBRAZ - Obránci zvířat, z. s. |
|
NFNZ - Nadační fond nezávislé žurnalistiky |
|
Centrum Anabell, z. ú. |
|
Sdružení pro integraci a migraci, o. p. s. |
Podobně sociální sítě (43221)
Dius45000 |
|
Spolek Svobodné rádio49000 |
|
Click and feed, z.s.48000 |
|
Římskokatolická farnost Starý Rožmitál51000 |
|
Římskokatolická farnost Hvožďany51000 |
Novinky
Researchers are investigating a new treatment option for young women with the most common type of breast cancer through our OLIO clinical trial! The OLIO trial aims to build on a breakthrough from a previous trial that discovered a feature in the tumours of young women with hormone receptor (HR) positive, HER2 negative breast cancer—the most common type of breast cancer, which is often much more aggressive in premenopausal women. OLIO will test whether we can treat this feature with targeted treatments that will kill the cancer cell, and whether adding immunotherapy can provide the boost needed to prevent the cancer from returning. It will test if adding the medicines olaparib, or olaparib with durvalumab together, to standard chemotherapy before surgery, will do a better job of treating the cancer. Find out more about OLIO: https://www.breastcancertrials.org.au/trials/olio/ (fb)
Neo-N Cohort C is supercharging treatment for triple-negative breast cancer with dual immunotherapy! The original Neo-N trial examined whether a new drug called nivolumab helps control breast cancer when added to standard chemotherapy and found that 50% of patients on the trial had no evidence of breast cancer following treatment. Researchers are building on this finding with the Neo-N Cohort C trial, which will investigate if adding a new drug, relatlimab, given together with nivolumab, can further control breast cancer when added to standard chemotherapy for triple-negative breast cancer patients. Other studies have shown that nivolumab may be effective in removing cancer cells from the body, and this study is needed to work out the best way of giving this treatment. Find out more about this important research: https://www.breastcancertrials.org.au/trials/neo-n-2/ (fb)
Poslední komentáře
What an incredible initiative! 🌟 Supporting breast cancer research not only helps save lives today but also secures a healthier future for our daughters and granddaughters. Let's stand together for this cause! 💖 #HikeForHope #BreastCancerAwarenessdetail |
|
This Mother's Day, let’s make a difference and give hope to those affected by breast cancer. Every contribution counts! Join the fight for better treatments and prevention strategies. 🙌 #NoMoreLivesCutShort #BreastCancerTrialsdetail |
Poslední diskuze
1. What are some innovative fundraising strategies that NGOs like the ANZ Breast Cancer Trials Group can implement to support ongoing clinical trials and research efforts?Odpovědí: 3, Naposledy před 1 den detail |
|
2. How can we better educate communities about the importance of participating in clinical trials for breast cancer, especially in underrepresented populations?Odpovědí: 3, Naposledy před 1 den detail |
V okolí
4.5
NSW 2300
O společnosti
- H32, H30 -
Breast Cancer Trials Help keep our mums daughters and granddaughters safe Help keep our mums daughters and granddaughters safe MAKE A LIFESAVING GIFT THIS MOTHERS DAY HIKE FOR HOPE INTERESTED IN FUTURE QA EVENTS. THE BIG BOLD SWIM Together we are grounded and defined by one simple belief We can and we will find new and better treatments and prevention strategies for every person affected by breast cancer to save lives today tomorrow and forever 45 YEARS We have been improving treatments and saving lives since 1978. 93 TRIALS 93 clinical trials in various stages of recruitment followup analysis and publication. 17K WOMEN More than 17481 people have participated in our clinical trials.
Výzkum rakoviny
